Literature DB >> 23266797

A comparison of the scaling properties of the English, Spanish, French, and Chinese EQ-5D descriptive systems.

Nan Luo1, Minghui Li, Julie Chevalier, Andrew Lloyd, Michael Herdman.   

Abstract

PURPOSE: To compare the scaling properties of the English, Spanish, French, and Chinese versions of the EQ-5D-3L and EQ-5D-5L descriptive systems.
METHODS: Members of the general populations in the UK, Spain, France, and China were interviewed to measure the severity of health problems represented by the response labels used in the EQ-5D descriptive systems using a visual analog scale. Multiple linear regression models were used to compare the perceived label severity across the four language groups. Severity scores for labels from each EQ-5D-5L dimension scale were compared with each other to assess ordinality.
RESULTS: EQ-5D-5L and EQ-5D-3L labels used for describing different levels of health problems were rated differently, while those describing the same level of health problems were rated similarly. For example, the deviation of any group mean from the grand severity mean score for the label 'slight(ly)' was no larger than 5 points on a 0-100 scale for all five EQ-5D dimensions (p > 0.05 for all, t tests). Label ratings violating hypothesized ordinality of the EQ-5D-5L scales were observed in only a small proportion of respondents.
CONCLUSIONS: Our study provided some preliminary evidence supporting the ordinality and equivalence of the EQ-5D-5L and EQ-5D-3L descriptive systems across four major languages.

Mesh:

Year:  2012        PMID: 23266797     DOI: 10.1007/s11136-012-0342-0

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  17 in total

Review 1.  EQ-5D: a measure of health status from the EuroQol Group.

Authors:  R Rabin; F de Charro
Journal:  Ann Med       Date:  2001-07       Impact factor: 4.709

2.  Testing the equivalence of translations of widely used response choice labels: results from the IQOLA Project. International Quality of Life Assessment.

Authors:  S D Keller; J E Ware; B Gandek; N K Aaronson; J Alonso; G Apolone; J B Bjorner; J Brazier; M Bullinger; S Fukuhara; S Kaasa; A Leplège; R W Sanson-Fisher; M Sullivan; S Wood-Dauphinee
Journal:  J Clin Epidemiol       Date:  1998-11       Impact factor: 6.437

3.  Minimally important difference for patient-reported outcomes in psoriatic arthritis: Health Assessment Questionnaire and pain, fatigue, and global visual analog scales.

Authors:  Tiffany Kwok; Janet E Pope
Journal:  J Rheumatol       Date:  2010-03-15       Impact factor: 4.666

4.  A comparison of Likert scale and visual analogue scales as response options in children's questionnaires.

Authors:  H van Laerhoven; H J van der Zaag-Loonen; B H F Derkx
Journal:  Acta Paediatr       Date:  2004-06       Impact factor: 2.299

5.  Interpretation of response categories in patient-reported rating scales: a controlled study among people with Parkinson's disease.

Authors:  Ida Knutsson; Helena Rydström; Jan Reimer; Per Nyberg; Peter Hagell
Journal:  Health Qual Life Outcomes       Date:  2010-06-24       Impact factor: 3.186

6.  The minimally important difference for the health assessment questionnaire in rheumatoid arthritis clinical practice is smaller than in randomized controlled trials.

Authors:  Janet E Pope; Dinesh Khanna; Deborah Norrie; Janine M Ouimet
Journal:  J Rheumatol       Date:  2009-02       Impact factor: 4.666

7.  The minimally important difference and patient acceptable symptom state for the Raynaud's condition score in patients with Raynaud's phenomenon in a large randomised controlled clinical trial.

Authors:  Puja P Khanna; Paul Maranian; Jeff Gregory; Dinesh Khanna
Journal:  Ann Rheum Dis       Date:  2009-04-12       Impact factor: 19.103

8.  The minimally important difference for the fatigue visual analog scale in patients with rheumatoid arthritis followed in an academic clinical practice.

Authors:  Dinesh Khanna; Janet E Pope; Puja P Khanna; Michelle Maloney; Nooshin Samedi; Debbie Norrie; Gillian Ouimet; Ron D Hays
Journal:  J Rheumatol       Date:  2008-11-01       Impact factor: 4.666

9.  A one-item question with a Likert or Visual Analog Scale adequately measured current anxiety.

Authors:  Heather M Davey; Alexandra L Barratt; Phyllis N Butow; Jonathan J Deeks
Journal:  J Clin Epidemiol       Date:  2006-12-27       Impact factor: 6.437

10.  Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L).

Authors:  M Herdman; C Gudex; A Lloyd; Mf Janssen; P Kind; D Parkin; G Bonsel; X Badia
Journal:  Qual Life Res       Date:  2011-04-09       Impact factor: 4.147

View more
  17 in total

1.  Cross-cultural measurement equivalence of the EQ-5D-5L items for English-speaking Asians in Singapore.

Authors:  N Luo; Y Wang; C H How; K Y Wong; L Shen; E G Tay; J Thumboo; M Herdman
Journal:  Qual Life Res       Date:  2014-11-14       Impact factor: 4.147

2.  How the relationship between physical activity and health changes with age.

Authors:  Fernando Lera-Lopez; Andrea Ollo-López; Mirian Garrués-Irisarri; Juan M Cabasés; Eduardo Sánchez
Journal:  Eur J Ageing       Date:  2018-03-28

3.  Validation and comparison of the psychometric properties of the EQ-5D-3L and EQ-5D-5L instruments in Greece.

Authors:  John N Yfantopoulos; Athanasios E Chantzaras
Journal:  Eur J Health Econ       Date:  2016-06-04

4.  Comparing the validity and responsiveness of the EQ-5D-5L to the Oxford hip and knee scores and SF-12 in osteoarthritis patients 1 year following total joint replacement.

Authors:  Barbara L Conner-Spady; Deborah A Marshall; Eric Bohm; Michael J Dunbar; Tom W Noseworthy
Journal:  Qual Life Res       Date:  2018-02-08       Impact factor: 4.147

5.  Reliability and validity of the EQ-5D-5L compared to the EQ-5D-3L in patients with osteoarthritis referred for hip and knee replacement.

Authors:  Barbara L Conner-Spady; Deborah A Marshall; Eric Bohm; Michael J Dunbar; Lynda Loucks; Ammar Al Khudairy; Tom W Noseworthy
Journal:  Qual Life Res       Date:  2015-01-03       Impact factor: 4.147

6.  A cluster randomised, double-blind pilot and feasibility trial of an active behavioural physiotherapy intervention for acute whiplash-associated disorder (WAD)II.

Authors:  Taweewat Wiangkham; Joan Duda; M Sayeed Haque; Jonathan Price; Alison Rushton
Journal:  PLoS One       Date:  2019-05-09       Impact factor: 3.240

7.  Pragmatic cluster randomised double-blind pilot and feasibility trial of an active behavioural physiotherapy intervention for acute non-specific neck pain: a mixed-methods protocol.

Authors:  Taweewat Wiangkham; Sureeporn Uthaikhup; Alison B Rushton
Journal:  BMJ Open       Date:  2019-09-30       Impact factor: 2.692

8.  Impact of medication review via tele-expertise on unplanned hospitalizations at 3 months of nursing homes patients (TEM-EHPAD): study protocol for a randomized controlled trial.

Authors:  F Correard; M Montaleytang; M Costa; M Astolfi; K Baumstarck; S Loubière; K Amichi; P Auquier; P Verger; P Villani; S Honore; A Daumas
Journal:  BMC Geriatr       Date:  2020-04-20       Impact factor: 3.921

9.  Multinational evidence of the applicability and robustness of discrete choice modeling for deriving EQ-5D-5L health-state values.

Authors:  Paul F M Krabbe; Nancy J Devlin; Elly A Stolk; Koonal K Shah; Mark Oppe; Ben van Hout; Elise H Quik; A Simon Pickard; Feng Xie
Journal:  Med Care       Date:  2014-11       Impact factor: 2.983

10.  Experience-based VAS values for EQ-5D-3L health states in a national general population health survey in China.

Authors:  Sun Sun; Jiaying Chen; Paul Kind; Ling Xu; Yaoguang Zhang; Kristina Burström
Journal:  Qual Life Res       Date:  2014-09-24       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.